Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Chicago
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000264

Purpose

The purpose of this study is to examine the subjective, psychomotor, and reinforcing effects of combined alcohol and nitrous oxide intake in healthy volunteers.

Condition	Intervention	Phase
Opioid-Related Disorders Substance-Related Disorders	Drug: Nitrous oxide	Phase II

Drug Information available for: Ethanol Nitrous oxide

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Mood
Psychomotor performance
Cognitive performance
Choice of drug vs placebo

Estimated Enrollment:	0
Study Start Date:	September 1997

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000264

Locations

United States, Illinois
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States, 60637

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Chicago

Investigators

Principal Investigator:

James Zacny, Ph.D.

University of Chicago

More Information

Study ID Numbers:	NIDA-08391-16, R01-08391-16
Study First Received:	September 20, 1999
Last Updated:	August 16, 2005
ClinicalTrials.gov Identifier:	NCT00000264
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Mental Disorders
Nitrous Oxide
Substance-Related Disorders

Disorders of Environmental Origin
Opioid-Related Disorders
Ethanol

Additional relevant MeSH terms:

Disease
Physiological Effects of Drugs
Central Nervous System Depressants
Anesthetics
Pharmacologic Actions
Anesthetics, Inhalation
Pathologic Processes

Analgesics, Non-Narcotic
Sensory System Agents
Anesthetics, General
Therapeutic Uses
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on January 15, 2009